Regemat 3D Company

REGEMAT 3D is a biotech company focused on regenerative medicine and pioneer in a new and promising area called bioprinting, that uses 3D printing technologies for regenerative therapies. REGEMAT3D is a bioprinting modular system that integrates the latest advances in 3D printing and regenerative therapies to offer adapted solutions to fulfil research's needs. A tested and validated systems, it is adaptable to different types of tissues, to research the biggest unsolved biotechnology problems and to battle different kinds of pathologies, such as; Cardiovascular Disease (CVD), Peripheral Vascular Disease (PVD), Non-healing wounds, Spinal cord injury, Alzheimer´s Disease (AD), Parkinson´s Disease (PD), Musculoskeletal Disorders (MSDs), Autoimmune Disorders, Stroke, Diabetes, and Ocular Disease.
Industry: Geroscience
Headquarters: Armilla, Andalucia, Spain
Zip: 11-50
Founded Date: 2015-01-01
Employees Number: 11-50
Acquisitions Number: 1
Investors Number: 1095799
Total Funding: Less than $1M
Estimated Revenue: Less than $1M
Last Funding Date: Equity Crowdfunding
Last Funding Type: info@regemat3d.com

Visit Website
https://twitter.com/regemat3D
https://www.crunchbase.com/organization/regemat-3d
Register and Claim Ownership